Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs HRTS overlap: 59% of top holdings shared

Bottom line

How much do FHLC and HRTS overlap?

59% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 59.6% of FHLC's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 45), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCHRTS
Weight overlap (top 25)59%
Shared holdings15
Weight in shared holdings59.6%51.9%
Total positions33745
Expense ratio0.084%0.75%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FHLC and HRTS have in common

Holding% of FHLC% of HRTSOverlap
Eli Lilly & Co13.35%11.52%11.52%
Johnson & Johnson8.93%3.59%3.59%
AbbVie Inc6.42%2.40%2.40%
UnitedHealth Group Inc5.44%5.24%5.24%
Merck & Co Inc4.66%4.27%4.27%
Thermo Fisher Scientific Inc3.09%3.97%3.09%
Amgen Inc3.00%1.91%1.91%
Abbott Laboratories2.66%2.61%2.61%
Gilead Sciences Inc2.34%3.43%2.34%
Bristol-Myers Squibb Co1.93%2.09%1.93%
Danaher Corp1.80%2.66%1.80%
Vertex Pharmaceuticals Inc1.76%2.93%1.76%
Medtronic PLC1.59%1.88%1.59%
McKesson Corp1.52%1.71%1.52%
Regeneron Pharmaceuticals Inc1.15%1.67%1.15%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Pfizer Inc — 2.06%
  2. CVS Health Corp — 1.92%
  3. Intuitive Surgical Inc — 1.82%
  4. Stryker Corp — 1.62%
  5. Elevance Health Inc — 1.19%
  6. Cigna Group/The — 1.06%
  7. Boston Scientific Corp — 1.00%
  8. HCA Healthcare Inc — 0.91%
  9. Cencora Inc — 0.83%
  10. Cardinal Health Inc — 0.78%

Only in HRTS

  1. Novo Nordisk A/S — 5.24%
  2. Roche Holding AG — 4.50%
  3. AstraZeneca PLC — 4.00%
  4. Novartis AG — 3.38%
  5. Revolution Medicines Inc — 3.33%
  6. Bridgebio Pharma Inc — 2.59%
  7. Cytokinetics Inc — 2.52%
  8. Teva Pharmaceutical Industries — 2.06%
  9. Dexcom Inc — 1.92%
  10. Edwards Lifesciences Corp — 1.75%

Asset mix

Asset typeFHLCHRTS
Stocks99.7%99.2%
Cash & short-term funds0.2%0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFHLCHRTS
US96.5%74.9%
CH0.1%7.9%
DK—7.0%
GB0.5%4.0%
IE2.2%1.9%
IL—2.1%
JP—1.3%
CA0.2%0.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FHLC and HRTS overlap?
About 59% by weight. 15 securities appear in both funds' top 25 holdings; they make up 59.6% of FHLC's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and HRTS have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, Johnson & Johnson, Thermo Fisher Scientific Inc.
Should I own both FHLC and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or HRTS?
FHLC is broader, with 337 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.